Showing 8321-8330 of 8647 results for "".
- FDA Clears First Daily Disposable Silicone Hydrogel Contact Lens Coated with Modified Formula of Tangible Hydra-PEGhttps://modernod.com/news/fda-clears-first-daily-disposable-silicone-hydrogel-contact-lens-coated-with-modified-formula-of-tangible-hydra-peg/2479611/Tangible Science announced that the FDA has cleared the first daily disposable silicone hydrogel contact lens coated with a modified formula of Tangible Hydra-PEG. Tangible Hydra-PEG is an innovative coating applied to custom contact lenses to improve lens wettability and deposit resistanc
- The Number of Optometric Practices Offering neurolens Contoured Prism Lenses More Than Quadrupled in 2018https://modernod.com/news/the-number-of-optometric-practices-offering-neurolens-contoured-prism-lenses-more-than-quadrupled-in-2018/2479617/Costa Mesa, California-based neurolens announced that adoption of their prescription lenses has grown among US optometric (OD) practices and by year end, 31 states will carry the company’s neurolenses and the neurolens measurement device. neurolenses are the first and only prescripti
- GenSight Biologics Reports Sustained Quality of Life Improvements at Week 72 of Phase 3 REVERSE Clinical Trialhttps://modernod.com/news/gensight-biologics-reports-sustained-quality-of-life-improvements-at-week-72-of-phase-3-reverse-clinical-trial/2479619/GenSight Biologics reported that week 72 analyses of the data from its phase 3 REVERSE clinical trial revealed a sustained improvement in composite scores and selected sub-scores of a questionnaire used to measure patient perceptions of vision-related quality of life and ability to carry out dail
- Study: Glaukos iStent inject Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burdenhttps://modernod.com/news/study-glaukos-istent-inject-implantation-with-concomitant-cataract-surgery-provides-sustained-reduction-in-iop-and-medication-burden/2479620/Glaukos announced that a single-site international study of glaucoma subjects recently published in Ophthalmology and Therapy showed that the iStent inject Trabecular Micro-Bypass System, combined with cataract surgery, achieved a 37% reduction in mean IOP to 14.3 mmHg after 3 years of f
- Opternative Changes Names to Visibly To Better Reflect Eye Care Industry Partnershipshttps://modernod.com/news/opternative-changes-names-to-visibly-to-better-reflect-eye-care-industry-partnerships/2479622/Opternative announced that it has changed its name Visibly to better represent the eye care industry, according to a company news release. “We understand that our previous company name, Opternative, carried a negative connotation in the eye care industry and positioned the brand as a
- Wills Eye Hospital’s Training in Ophthalmology Voted #1 Top Eye Residency Program in Nationhttps://modernod.com/news/wills-eye-hospitals-training-in-ophthalmology-voted-1-top-eye-residency-program-in-nation/2479623/The Wills Eye at Jefferson Residency Program in Philadelphia has been voted the #1 medical education training program in ophthalmology in the nation, according to Doximity.com. The Wills Eye Hospital faculty serve as the department of Ophthalmology at Thomas Jefferson
- Federal Trade Commission Penalizes Online Sellers for Violating Contact Lens Rule, Bans Them from Selling Lenses in Futurehttps://modernod.com/news/federal-trade-commission-penalizes-online-sellers-for-violating-contact-lens-rule-bans-them-from-selling-lenses-in-future/2476152/The Healthcare Alliance for Patient Safety released a statement following yesterday’s announcement from the Federal Trade Commission (FTC)
- Study: Dietary Supplements Don’t Prevent Chronic Diseasehttps://modernod.com/news/study-dietary-supplements-dont-prevent-chronic-disease/2476158/As the US nutritional and dietary supplements market remains robust — an estimated $41.1 billion in sales in 2016 — the Academy of Nutrition and Dietetics is cautioning against the routine and indiscriminate use of these dietary add-ons, according to a Medscape
- Takeda Shareholders Back Shire Purchasehttps://modernod.com/news/takeda-shareholders-back-shire-purchase/2479627/Shareholders of Japanese pharmaceutical company Takeda overwhelmingly voted in favor of acquiring UK-based Shire. The deal, currently valued at about $58 billion dollars, makes Takeda a top 10 global drugmaker by sales. Takeda shareholders on Wednesday voted 88 percent in favor in of thee
- Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Studyhttps://modernod.com/news/eyenovia-completes-patient-enrollment-in-microstat-mist-1-study-and-enrolls-first-patient-in-mist-2-study/2476167/Eyenovia announced that it has completed patient enrollment in its phase 3 MIST-1 study and enrolled the first patient in its second phase 3 study, the MIST-2 trial, for the company’s phase 3 MicroStat program for pharmacologic mydriasis. “We are pleased to